• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

鉴定 m6A 阅读器 IGF2BP2 在阿尔茨海默病中的功能和机制。

Identification of the function and mechanism of m6A reader IGF2BP2 in Alzheimer's disease.

机构信息

Department of Neurology, The First Hospital of Changsha, Changsha, Hunan Province, China.

Department of Hepatopancreatobiliary Surgery, The Third Xiangya Hospital, Central South University, Changsha, Hunan Province, China.

出版信息

Aging (Albany NY). 2021 Oct 27;13(21):24086-24100. doi: 10.18632/aging.203652.

DOI:10.18632/aging.203652
PMID:34705667
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8610118/
Abstract

Alzheimer's disease, the most common form of dementia in the elderly, is a kind of neurodegenerative disease. However, its pathogenesis and diagnosis remain unclear. M6A is related to nervous system development and neurodegenerative diseases. Here in this study, using multiple RNA-seq datasets of Alzheimer's brain tissues, along with bioinformatic analysis, we innovatively found that m6A reader protein IGF2BP2 was abnormally highly expressed in Alzheimer's patients. After compared between Alzheimer's and normal brain samples, and between IGF2BP2- high and IGF2BP2- low subgroups of Alzheimer's patients, we took the shared differentially expressed genes as the relevant gene sets of IGF2PB2 affecting Alzheimer's disease occurrence for subsequent analysis. Then, weight gene correlation analysis was conducted and 17 functional modules were identified. The module that most positively correlated with Alzheimer's disease and IGF2PB2-high subgroups were mainly participated in ECM receptor interaction, focal adhesion, cytokine-cytokine receptor interaction, and TGF-beta signaling pathway. Afterwards, a hub gene-based model including 20 genes was constructed by LASSO regression and validated by ROC curve for Alzheimer diagnosis. Finally, we preliminarily elucidated that IGF2BP2 could bind with mRNAs in a m6A-dependent manner. This study first elucidates the pathogenic role of IGF2BP2 in Alzheimer's disease. IGF2BP2 and its relevant m6A modifications are potential to be new diagnostic and therapeutic targets for Alzheimer's patients.

摘要

阿尔茨海默病是老年人最常见的痴呆症类型,属于一种神经退行性疾病。然而,其发病机制和诊断仍然不清楚。m6A 与神经系统发育和神经退行性疾病有关。在本研究中,我们创新性地使用了多个阿尔茨海默病脑组织的 RNA-seq 数据集,并结合生物信息学分析,发现 m6A 阅读蛋白 IGF2BP2 在阿尔茨海默病患者中异常高表达。在阿尔茨海默病患者与正常脑组织样本之间、IGF2BP2 高表达与 IGF2BP2 低表达亚组的阿尔茨海默病患者之间进行比较后,我们将共享的差异表达基因作为 IGF2PB2 影响阿尔茨海默病发生的相关基因集,用于后续分析。然后,进行加权基因相关性分析,鉴定出 17 个功能模块。与阿尔茨海默病和 IGF2BP2 高表达亚组最正相关的模块主要参与细胞外基质受体相互作用、粘着斑、细胞因子-细胞因子受体相互作用和 TGF-β信号通路。之后,通过 LASSO 回归构建了一个基于枢纽基因的包含 20 个基因的模型,并通过 ROC 曲线进行验证,用于阿尔茨海默病的诊断。最后,我们初步阐明了 IGF2BP2 可以以 m6A 依赖的方式与 mRNAs 结合。本研究首次阐明了 IGF2BP2 在阿尔茨海默病中的致病作用。IGF2BP2 及其相关的 m6A 修饰可能成为阿尔茨海默病患者新的诊断和治疗靶点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc9e/8610118/22f7c8e27321/aging-13-203652-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc9e/8610118/a37cb73dbaee/aging-13-203652-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc9e/8610118/81ebf570ad9c/aging-13-203652-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc9e/8610118/01f619bd1c07/aging-13-203652-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc9e/8610118/5d7815c0ed0e/aging-13-203652-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc9e/8610118/55964f9afece/aging-13-203652-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc9e/8610118/22f7c8e27321/aging-13-203652-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc9e/8610118/a37cb73dbaee/aging-13-203652-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc9e/8610118/81ebf570ad9c/aging-13-203652-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc9e/8610118/01f619bd1c07/aging-13-203652-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc9e/8610118/5d7815c0ed0e/aging-13-203652-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc9e/8610118/55964f9afece/aging-13-203652-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc9e/8610118/22f7c8e27321/aging-13-203652-g006.jpg

相似文献

1
Identification of the function and mechanism of m6A reader IGF2BP2 in Alzheimer's disease.鉴定 m6A 阅读器 IGF2BP2 在阿尔茨海默病中的功能和机制。
Aging (Albany NY). 2021 Oct 27;13(21):24086-24100. doi: 10.18632/aging.203652.
2
Bioinformatic identification reveals a m6A-binding protein, IGF2BP2, as a novel tumor-promoting gene signature in thyroid carcinoma.生物信息学鉴定揭示了 m6A 结合蛋白 IGF2BP2 是甲状腺癌中一种新的促肿瘤基因特征。
Naunyn Schmiedebergs Arch Pharmacol. 2024 Aug;397(8):5663-5676. doi: 10.1007/s00210-024-02961-8. Epub 2024 Jan 30.
3
IGF2BP2 promotes the progression of ovarian endometriosis by regulating m6A-modified MEIS2 and GATA6.IGF2BP2 通过调节 m6A 修饰的 MEIS2 和 GATA6 促进卵巢子宫内膜异位症的进展。
Int J Biochem Cell Biol. 2022 Nov;152:106296. doi: 10.1016/j.biocel.2022.106296. Epub 2022 Sep 13.
4
The analysis of N6-methyladenosine regulators impacting the immune infiltration in clear cell renal cell carcinoma.影响肾透明细胞癌免疫浸润的N6-甲基腺苷调节剂分析
Med Oncol. 2022 Jan 29;39(4):41. doi: 10.1007/s12032-021-01645-0.
5
N6-methyladenosine reader YTH N6-methyladenosine RNA binding protein 3 or insulin like growth factor 2 mRNA binding protein 2 knockdown protects human bronchial epithelial cells from hypoxia/reoxygenation injury by inactivating p38 MAPK, AKT, ERK1/2, and NF-κB pathways.N6-甲基腺苷阅读器 YTH N6-甲基腺苷 RNA 结合蛋白 3 或胰岛素样生长因子 2 mRNA 结合蛋白 2 敲低通过使 p38 MAPK、AKT、ERK1/2 和 NF-κB 通路失活来保护人支气管上皮细胞免受缺氧/复氧损伤。
Bioengineered. 2022 May;13(5):11973-11986. doi: 10.1080/21655979.2021.1999550.
6
Immunological characterization and diagnostic models of RNA N6-methyladenosine regulators in Alzheimer's disease.阿尔茨海默病中 RNA N6-甲基腺苷调节因子的免疫特征和诊断模型。
Sci Rep. 2023 Sep 4;13(1):14588. doi: 10.1038/s41598-023-41129-x.
7
IGF2BP2 serves as a core m6A regulator in head and neck squamous cell carcinoma.IGF2BP2 作为核心 m6A 调节剂在头颈部鳞状细胞癌中发挥作用。
Biosci Rep. 2022 Nov 30;42(11). doi: 10.1042/BSR20221311.
8
IGF2BP2 knockdown suppresses thyroid cancer progression by reducing the expression of long non-coding RNA HAGLR.IGF2BP2 敲低通过降低长非编码 RNA HAGLR 的表达抑制甲状腺癌进展。
Pathol Res Pract. 2021 Sep;225:153550. doi: 10.1016/j.prp.2021.153550. Epub 2021 Jul 13.
9
Influence of N6-methyladenosine (m6A) modification on cell phenotype in Alzheimer's disease.N6-甲基腺苷(m6A)修饰对阿尔茨海默病中细胞表型的影响。
PLoS One. 2023 Aug 7;18(8):e0289068. doi: 10.1371/journal.pone.0289068. eCollection 2023.
10
N6-methyladenosine (m6A) modification and its clinical relevance in cognitive dysfunctions.N6-甲基腺苷(m6A)修饰及其在认知功能障碍中的临床意义。
Aging (Albany NY). 2021 Aug 30;13(16):20716-20737. doi: 10.18632/aging.203457.

引用本文的文献

1
IGF2BP2 Regulates the Progression of Alzheimer's Disease Through m6A-Mediated NLRP3 Inflammasome.IGF2BP2通过m6A介导的NLRP3炎性小体调节阿尔茨海默病的进展。
Immun Inflamm Dis. 2025 Jan;13(1):e70121. doi: 10.1002/iid3.70121.
2
Exploring the methyl-verse: Dynamic interplay of epigenome and m6A epitranscriptome.探索甲基化领域:表观基因组与m6A表转录组的动态相互作用
Mol Ther. 2025 Feb 5;33(2):447-464. doi: 10.1016/j.ymthe.2024.12.003. Epub 2024 Dec 9.
3
D-galactose Induces Senescence in Adult Mouse Neural Stem Cells by Imbalanced Oxidant and Antioxidant Activity and Differential Expression of Specific Hub Genes.

本文引用的文献

1
Melatonin: Regulation of Biomolecular Condensates in Neurodegenerative Disorders.褪黑素:神经退行性疾病中生物分子凝聚物的调控
Antioxidants (Basel). 2021 Sep 17;10(9):1483. doi: 10.3390/antiox10091483.
2
N6-methyladenosine (m6A) modification and its clinical relevance in cognitive dysfunctions.N6-甲基腺苷(m6A)修饰及其在认知功能障碍中的临床意义。
Aging (Albany NY). 2021 Aug 30;13(16):20716-20737. doi: 10.18632/aging.203457.
3
N6-methyladenosine dynamics in neurodevelopment and aging, and its potential role in Alzheimer's disease.
D-半乳糖通过氧化还原失衡和特定枢纽基因的差异表达诱导成年小鼠神经干细胞衰老。
Mol Neurobiol. 2025 Apr;62(4):4250-4263. doi: 10.1007/s12035-024-04546-1. Epub 2024 Oct 19.
4
RNA methylation in neurodevelopment and related diseases.神经发育及相关疾病中的RNA甲基化
Acta Biochim Biophys Sin (Shanghai). 2024 Sep 27;56(12):1723-1732. doi: 10.3724/abbs.2024159.
5
METTL14 inhibits Aβ1-42-induced neuronal injury through regulating the stability of CBLN4 mRNA in Alzheimer's disease.METTL14 通过调节阿尔茨海默病中 CBLN4 mRNA 的稳定性来抑制 Aβ1-42 诱导的神经元损伤。
J Bioenerg Biomembr. 2024 Oct;56(5):495-504. doi: 10.1007/s10863-024-10036-9. Epub 2024 Sep 5.
6
mC RNA methylation: a potential mechanism for infectious Alzheimer's disease.mRNA甲基化:感染性阿尔茨海默病的一种潜在机制。
Front Cell Dev Biol. 2024 Aug 8;12:1440143. doi: 10.3389/fcell.2024.1440143. eCollection 2024.
7
Fat Mass and Obesity-Associated Protein Regulates Granulosa Cell Aging by Targeting Matrix Metalloproteinase-2 Gene Via an N6-Methyladenosine-YT521-B Homology Domain Family Member 2-Dependent Pathway in Aged Mice.脂肪量和肥胖相关蛋白通过 N6-甲基腺苷-YT521-B 同源结构域家族成员 2 依赖性途径靶向基质金属蛋白酶-2 基因调节老年小鼠颗粒细胞衰老。
Reprod Sci. 2024 Nov;31(11):3498-3511. doi: 10.1007/s43032-024-01632-6. Epub 2024 Jul 12.
8
β-amyloid accumulation enhances microtubule associated protein tau pathology in an APP/MAPT mouse model of Alzheimer's disease.在阿尔茨海默病的APP/MAPT小鼠模型中,β-淀粉样蛋白积累会增强微管相关蛋白tau的病变。
Front Neurosci. 2024 Mar 20;18:1372297. doi: 10.3389/fnins.2024.1372297. eCollection 2024.
9
N-Methyladenosine in Vascular Aging and Related Diseases: Clinical Perspectives.N6-甲基腺苷在血管衰老及相关疾病中的作用:临床展望。
Aging Dis. 2024 Aug 1;15(4):1447-1473. doi: 10.14336/AD.2023.0924-1.
10
Emerging Roles for DNA 6mA and RNA m6A Methylation in Mammalian Genome.DNA 6mA 和 RNA m6A 甲基化在哺乳动物基因组中的新兴作用。
Int J Mol Sci. 2023 Sep 9;24(18):13897. doi: 10.3390/ijms241813897.
N6-甲基腺苷在神经发育和衰老中的动态变化,及其在阿尔茨海默病中的潜在作用。
Genome Biol. 2021 Jan 5;22(1):17. doi: 10.1186/s13059-020-02249-z.
4
Genetic variants in mA regulators are associated with gastric cancer risk.mA 调节因子中的遗传变异与胃癌风险相关。
Arch Toxicol. 2021 Mar;95(3):1081-1088. doi: 10.1007/s00204-020-02958-1. Epub 2021 Jan 4.
5
Advances in the profiling of N-methyladenosine (mA) modifications.m6A 修饰谱分析的研究进展。
Biotechnol Adv. 2020 Dec;45:107656. doi: 10.1016/j.biotechadv.2020.107656. Epub 2020 Nov 9.
6
Altered Expression of the m6A Methyltransferase METTL3 in Alzheimer's Disease.METTL3 在阿尔茨海默病中的表达改变。
eNeuro. 2020 Sep 8;7(5). doi: 10.1523/ENEURO.0125-20.2020. Print 2020 Sep/Oct.
7
Tauopathy in the young autistic brain: novel biomarker and therapeutic target.年轻自闭症患者大脑中的 Tau 病:新型生物标志物和治疗靶点。
Transl Psychiatry. 2020 Jul 13;10(1):228. doi: 10.1038/s41398-020-00904-4.
8
The potential role of RNA N6-methyladenosine in Cancer progression.RNA N6-甲基腺苷在癌症进展中的潜在作用。
Mol Cancer. 2020 May 12;19(1):88. doi: 10.1186/s12943-020-01204-7.
9
Clinical Significance of an m6A Reader Gene, , in Head and Neck Squamous Cell Carcinoma.一种m6A阅读蛋白基因在头颈部鳞状细胞癌中的临床意义
Front Mol Biosci. 2020 Apr 24;7:68. doi: 10.3389/fmolb.2020.00068. eCollection 2020.
10
Abnormality of m6A mRNA Methylation Is Involved in Alzheimer's Disease.m6A mRNA甲基化异常与阿尔茨海默病有关。
Front Neurosci. 2020 Feb 28;14:98. doi: 10.3389/fnins.2020.00098. eCollection 2020.